Efficacy of EZH2 Inhibitory Drugs in Human Papillomavirus-Positive and Human Papillomavirus-Negative Oropharyngeal Squamous Cell Carcinomas
Clinical Epigenetics - Germany
doi 10.1186/s13148-017-0390-y
Full Text
Open PDFAbstract
Available in full text
Date
September 6, 2017
Authors
Publisher
Springer Science and Business Media LLC